Mengye Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mengye Guo has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Annick D. Van Den Abbeele
Department of Imaging Dana‐Farber/Harvard Cancer Center 450 Brookline Avenue, DL101 Boston MA 02215 USA
1 shared publication- Armin Schwartzman
University of California, San Diego
1 shared publication - Geoffrey H. Tison
Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, Calif
1 shared publication - Jeffrey T. Yap
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
1 shared publication - Khurram Nasir
The Johns Hopkins Hospital
1 shared publication - Matthew A. Allison
University of California San Diego
1 shared publication
Latest Publications
- Open Access
- 1 September 2015
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 9 (5) , 406-414
Multisite extracoronary calcification indicates increased risk of coronary heart disease and all-cause mortality: The Multi-Ethnic Study of Atherosclerosis
- 1 September 2015
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 9 (5) , 406-414
Open AccessMultisite extracoronary calcification indicates increased risk of coronary heart disease and all-cause mortality: The Multi-Ethnic Study of Atherosclerosis
Voxelwise single‐subject analysis of imaging metabolic response to therapy in neuro‐oncology
F‐18‐Fluorodeoxyglucose positron emission tomography (FDG‐PET) has been used to evaluate the metabolic response of metastatic brain tumours to treatment by comparing their tumour glucose metabolism before and after treatment. The standard analysis based on regions‐of‐interest has the advantage of simplicity. However, it is by definition restricted to those regions and is subject to observer variability. In addition, the observed changes in tumour metabolism are often confounded by normal changes in the tissue background, which can be heterogenous. We propose an analysis pipeline for automatically detecting the change at each voxel in the entire brain of a single subject, while adjusting for changes in the background. The complete analysis includes image registration, segmentation, a hierarchical model for background adjustment and voxelwise statistical comparisons. We demonstrate the method's ability to identify areas of tumour response and/or progression in two subjects enrolled in a clinical trial using FDG‐PET to evaluate lapatinib for the treatment of brain metastases in breast cancer patients. Copyright © 2014 John Wiley & Sons, Ltd.
Voxelwise single‐subject analysis of imaging metabolic response to therapy in neuro‐oncology
F‐18‐Fluorodeoxyglucose positron emission tomography (FDG‐PET) has been used to evaluate the metabolic response of metastatic brain tumours to treatment by comparing their tumour glucose metabolism before and after treatment. The standard analysis based on regions‐of‐interest has the advantage of simplicity. However, it is by definition restricted to those regions and is subject to observer variability. In addition, the observed changes in tumour metabolism are often confounded by normal changes in the tissue background, which can be heterogenous. We propose an analysis pipeline for automatically detecting the change at each voxel in the entire brain of a single subject, while adjusting for changes in the background. The complete analysis includes image registration, segmentation, a hierarchical model for background adjustment and voxelwise statistical comparisons. We demonstrate the method's ability to identify areas of tumour response and/or progression in two subjects enrolled in a clinical trial using FDG‐PET to evaluate lapatinib for the treatment of brain metastases in breast cancer patients. Copyright © 2014 John Wiley & Sons, Ltd.